Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

24.34

+0.06 (0.25%)

At close: Sep 8, 2026, 4:00 PM EDT

24.37

+0.03 (0.12%)

After-hours: Sep 8, 2026, 7:59 PM EDT

Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	169.87	70.5	47.92	65.06	90.03	139.07
Short-Term Investments	174.38	156.49	174.37	281.34	408.17	214
Cash & Short-Term Investments	344.26	226.98	222.29	346.4	498.2	353.06
Cash Growth	73.98%	2.11%	-35.83%	-30.47%	41.11%	-48.70%
Accounts Receivable	49.51	50.37	41.73	37.97	40.06	17.41
Other Receivables	1.8	1.5	1.3	1	0.8	1.4
Receivables	51.31	51.87	43.03	38.97	40.86	18.81
Inventory	10.5	9.82	8.44	14.45	14.45	19.26
Prepaid Expenses	14.5	11.52	9.99	10.37	8.64	11.62
Total Current Assets	420.56	300.19	283.75	410.19	562.15	402.75
Property, Plant & Equipment	68.57	74.72	94.38	120.32	164.21	172.94
Long-Term Investments	27.48	13.23	33.66	-	-	217.15
Goodwill	118.97	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	0.88	1.73	3.43	5.13	6.83	8.53
Other Long-Term Assets	4.21	3.9	5.18	6.52	4.46	3.01
Total Assets	640.68	512.74	539.38	661.13	856.62	923.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.24	6.47	7.27	7.72	8.08	3.31
Accrued Expenses	20.39	22.72	20.67	20.39	24.1	22.2
Current Portion of Long-Term Debt	-	4.64	0.87	-	-	-
Current Portion of Leases	8.82	8.92	10.24	9.38	9.23	5.06
Current Income Taxes Payable	-	0.54	0.18	0.06	0.19	0.39
Current Unearned Revenue	53.26	45.19	55.69	48.63	64.12	80.46
Other Current Liabilities	-	1.43	3.15	1.84	4.07	2.39
Total Current Liabilities	87.71	89.92	98.05	88.02	109.79	113.81
Long-Term Debt	334.88	126.57	132.41	130.66	125.36	-
Long-Term Leases	66.8	70.23	79.15	89.39	98.77	106.69
Long-Term Unearned Revenue	0.61	1.01	27.26	44.79	58.6	98.75
Other Long-Term Liabilities	0.02	0.02	0.02	-	-	-
Total Liabilities	490.02	287.74	336.89	352.86	392.52	319.24

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,566	1,582	1,506	1,453	1,387	1,324
Retained Earnings	-1,423	-1,363	-1,304	-1,144	-919.08	-718.89
Comprehensive Income & Other	-0.21	0.25	0.17	0.22	-4.12	-1.14
Total Common Equity	142.91	218.79	202.71	308.4	464.17	603.99
Minority Interest	7.75	6.21	-0.22	-0.12	-0.07	0.11
Shareholders' Equity	150.66	225	202.49	308.28	464.1	604.1
Total Liabilities & Equity	640.68	512.74	539.38	661.13	856.62	923.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	410.5	210.36	222.67	229.43	233.36	111.74
Net Cash (Debt)	-38.76	29.86	33.29	116.97	264.83	458.47
Net Cash Growth	-	-10.30%	-71.54%	-55.83%	-42.23%	-34.41%
Net Cash Per Share	-0.25	0.20	0.23	0.81	1.86	3.27
Filing Date Shares Outstanding	159.6	153.98	148.58	145.09	143.23	141.58
Total Common Shares Outstanding	159.06	153.78	147.77	145.08	143.11	141.39
Working Capital	332.85	210.27	185.7	322.17	452.36	288.94
Book Value Per Share	0.90	1.42	1.37	2.13	3.24	4.27
Tangible Book Value	23.06	98.1	80.31	184.3	338.37	476.49
Tangible Book Value Per Share	0.14	0.64	0.54	1.27	2.36	3.37
Machinery	-	54.39	59.33	61.36	56.7	48.88
Construction In Progress	-	1.1	2.57	3.41	7.63	5.66
Leasehold Improvements	-	73.11	73.28	74.73	72.4	65.96

SEC Filings: 10-K · 10-Q